Search    GO ›
Home // What We Do // WHF Roadmaps // Cholesterol Roadmap

Cholesterol Roadmap

Global Roadmap to tackle cholesterol in secondary and primary prevention of CVD and in patients with familial hypercholesterolaemia

 

Soon to be launched, the World Heart Federation’s Cholesterol Roadmap calls for:

More awareness of healthier lifestyles and diet

Increased screening and testing for cholesterol in communities

More effective initiation of statin treatment and adherence to drug treatments in primary and secondary prevention of CVD

Better detection and treatment of patients with familial hypercholesterolaemia (FH)

Better physician education and support

Reform of drug availability and affordability

For primary prevention WHO recommends a total risk approach to identify people at high risk of having a heart attack and stroke, taking account of all the major risk factors including blood cholesterol, but most people are unaware of their cholesterol levels or their overall cardiovascular risk.

For patients who have already developed CVD reducing cholesterol is central to secondary prevention. But a large treatment gap exists in proportions of patients achieving national targets for cholesterol lowering despite the overwhelming evidence that statins reduce risk and improve life expectancy.

“There are more than 17 million deaths caused by cardiovascular disease each year. High levels of cholesterol are known to increase the risk of heart attacks and strokes. We hope by tackling the ‘roadblocks’ with the solutions set out in this Roadmap we can reduce the number of deaths.”

Carlos Castro, Executive Director of the patients’ heart health association, PACO

Cholesterol Roadmap preview event presentations:

Welcome Address by Professor Salim Yusuf, World Heart Federation (WHF) President

The importance of cholesterol by Professor Salim Yusuf, World Heart Federation (WHF) President

The World Heart Federation Roadmap on Cholesterol - Primary and Secondary Prevention by Professor David Wood, WHF President Elect

Family Hypercholesterolemia by Professor Alberico Catapano, Dept of Pharmacological & Biomolecular Science, University of Milan, Italy

Cholesterol - A view from low and middle-income countries by Professor Jose Rocha Faria Neto, Pontifícia Universidade Católica do Paraná, Curitiba, PR Brazil

Cholesterol in the global agenda by Jeremiah Mwangi – Director of Advocacy and Global Policy

Cholesterol - The patient voice by Carlos Castro, PACO